HABIT
发表于 2025-3-21 18:36:48
书目名称Combination Therapy in Hypertension影响因子(影响力)<br> http://impactfactor.cn/2024/if/?ISSN=BK0229860<br><br> <br><br>书目名称Combination Therapy in Hypertension影响因子(影响力)学科排名<br> http://impactfactor.cn/2024/ifr/?ISSN=BK0229860<br><br> <br><br>书目名称Combination Therapy in Hypertension网络公开度<br> http://impactfactor.cn/2024/at/?ISSN=BK0229860<br><br> <br><br>书目名称Combination Therapy in Hypertension网络公开度学科排名<br> http://impactfactor.cn/2024/atr/?ISSN=BK0229860<br><br> <br><br>书目名称Combination Therapy in Hypertension被引频次<br> http://impactfactor.cn/2024/tc/?ISSN=BK0229860<br><br> <br><br>书目名称Combination Therapy in Hypertension被引频次学科排名<br> http://impactfactor.cn/2024/tcr/?ISSN=BK0229860<br><br> <br><br>书目名称Combination Therapy in Hypertension年度引用<br> http://impactfactor.cn/2024/ii/?ISSN=BK0229860<br><br> <br><br>书目名称Combination Therapy in Hypertension年度引用学科排名<br> http://impactfactor.cn/2024/iir/?ISSN=BK0229860<br><br> <br><br>书目名称Combination Therapy in Hypertension读者反馈<br> http://impactfactor.cn/2024/5y/?ISSN=BK0229860<br><br> <br><br>书目名称Combination Therapy in Hypertension读者反馈学科排名<br> http://impactfactor.cn/2024/5yr/?ISSN=BK0229860<br><br> <br><br>
喷油井
发表于 2025-3-21 21:29:41
http://reply.papertrans.cn/23/2299/229860/229860_2.png
连累
发表于 2025-3-22 02:22:41
http://reply.papertrans.cn/23/2299/229860/229860_3.png
NIP
发表于 2025-3-22 05:16:00
Sir Philip Sidney, Cultural Icon studies indicate that administration of low-dose combination therapy enables adequate blood pressure control to be achieved in all subgroups of hypertensive patients, including the elderly, African–Americans, Caucasians, and patients with diabetes or metabolic syndrome.
eucalyptus
发表于 2025-3-22 08:52:59
Sir Philip Sidney, Cultural Iconbination therapy may result in greater decreases in systolic blood pressure, a higher rate of control of blood pressure, and a better adverse event profile than do component monotherapies at the same or higher doses.
Compassionate
发表于 2025-3-22 15:41:58
The Crisis in Church and State,percentage of controlled patients has decreased. Also, significantly, the lower target for blood pressure has created a greater challenge for physicians, who were already having difficulty achieving the 140/90 mmHg goal in their patients.
Compassionate
发表于 2025-3-22 17:33:41
Advantages of Combination Therapy Compared with Monotherapy,plementary antihypertensive drugs in combination is always associated with greater efficacy than uptitration of an individual antihypertensive agent and provides an improved adverse event profile compared with monotherapy.
intolerance
发表于 2025-3-22 22:49:09
Use of Combination Therapy in Special Populations, studies indicate that administration of low-dose combination therapy enables adequate blood pressure control to be achieved in all subgroups of hypertensive patients, including the elderly, African–Americans, Caucasians, and patients with diabetes or metabolic syndrome.
不规则
发表于 2025-3-23 04:33:04
http://reply.papertrans.cn/23/2299/229860/229860_9.png
傻
发表于 2025-3-23 09:04:25
http://reply.papertrans.cn/23/2299/229860/229860_10.png